Acording to CNN; On Thursday, Dr. Kent Brantly thought he
was going to die.
It was the ninth day since the American
missionary worker came down sick with Ebola in
Liberia.
His condition worsening by the minute, Brantly
called his wife to say goodbye.
Thankfully, the call was premature.
Brantly is back on his feet — literally — after
receiving a last-ditch, highly experimental drug.
Another American missionary with Ebola got the
same.
Brantly’s and Nancy Writebol’s conditions
significantly improved after receiving the
medication, sources say. Brantly was able to walk
into Emory University Hospital in Atlanta after
being evacuated to the United States last week,
and Writebol is expected to arrive in Atlanta on
Tuesday.
On July 22, Brantly woke up feeling feverish.
Fearing the worst, Brantly immediately isolated
himself. Writebol’s symptoms started three days
later. A rapid field blood test confirmed the
infection in both of them after they had become ill
with fever, vomiting and diarrhea.
It’s believed Brantly and Writebol, who worked
with the aid organization Samaritan’s Purse,
contracted Ebola from another health care worker
at their hospital in Liberia, although the official
Centers for Disease Control and Prevention case
investigation has yet to be released.
The experimental drug, known as ZMapp, was
developed by the biotech firm Mapp
Biopharmaceutical Inc., which is based in San
Diego. The patients were told that the treatment
had never been tried before in a human being but
had shown promise in small experiments with
monkeys.
Questions about this new Ebola drug
According to company documents, four monkeys
infected with Ebola survived after being given the
therapy within 24 hours after infection. Two of four
other monkeys that started therapy within 48
hours after infection also survived. One monkey
that was not treated died within five days of
exposure to the virus.
Brantly and Writebol were aware of the risk of
taking a new, little-understood treatment and gave
informed consent, according to two sources
familiar with the care of the missionary workers. In
the monkeys, the experimental serum had been
given within 48 hours of infection. Brantly didn’t
receive it until he’d been sick for nine days.
The medicine is a three-mouse monoclonal
antibody, meaning that mice were exposed to
fragments of the Ebola virus and then the
antibodies generated within the mice’s blood were
harvested to create the medicine. It works by
preventing the virus from entering and infecting
new cells.
The Ebola virus causes viral hemorrhagic fever,
which refers to a group of viruses that affect
multiple organ systems in the body and are often
accompanied by bleeding.
Early symptoms include sudden onset of fever,
weakness, muscle pain, headaches and a sore
throat. They later progress to vomiting, diarrhea,
impaired kidney and liver function — and
sometimes internal and external bleeding.
The ZMapp vials, stored at subzero temperatures,
reached the hospital in Liberia where Brantly and
Writebol were being treated Thursday morning.
Doctors were instructed to allow the serum to
thaw naturally without any additional heat. It was
expected that it would be eight to 10 hours before
the medicine could be given, according to a
source familiar with the process.
Brantly asked that Writebol be given the first dose
because he was younger and he thought he had a
better chance of fighting it, and she agreed.
However, as the first vial was still thawing,
Brantly’s condition took a sudden turn for the
worse. Please logon to http://www.chinedusamuel..com/2014/08/breaking-news-remedy-of-ebola-virus-is.html?m=1 to read the full story.

picture of brantly or i don't believe it